Replies to post #2650 on Galectin Therapeutics Inc. (GALT)

[gss2003]

I think the licensing deal is needed to move that high. The data for Melanoma and other Atopic Derm patients could bump it to say $3 if really good, but to get to $6+ a buyout or partnership is needed or they announce that X number of patients have had Cirrhosis reversed with GR-MD-02